BioMark Diagnostics Overview
Get informed when a big investor buys or sells
+ Follow280.12
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
BioMark Diagnostics's peg ratio stands at 280.12. That is above the sector sector average of 6.42. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
BioMark Diagnostics sits higher the its sector benchmark (6.42) with a PEG ratio of 280.12. That is roughly 4263.0% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 280.12 is attractive depends on BioMark Diagnostics's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how BioMark Diagnostics's PEG ratio evolved across reporting periods, while the comparison chart places BMKDF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
